GLP-1 Agonists & SGLT-2 Inhibitors: The Future of Diabetes Management and Weight Loss episode artwork

EPISODE · Oct 17, 2024 · 9 MIN

GLP-1 Agonists & SGLT-2 Inhibitors: The Future of Diabetes Management and Weight Loss

from This Podcast is Not Real · host Ana Guillen

In this episode of This Podcast is Not Real, our AI hosts explore the science behind two groundbreaking classes of medications for managing type 2 diabetes: GLP-1 agonists and SGLT-2 inhibitors. These drugs mimic natural hormones to regulate blood sugar, with added potential benefits for weight loss and improved health outcomes. We break down how they work, their effectiveness, and what sets them apart. As always, consulting a healthcare provider is crucial to find the right treatment. Join us to uncover the potential of these innovative medications in transforming diabetes care and promoting healthier living.

Episode metadata supplied by the publisher feed · Published Oct 17, 2024

Embed this episode

NOW PLAYING

GLP-1 Agonists & SGLT-2 Inhibitors: The Future of Diabetes Management and Weight Loss

0:00 9:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Podcast is Not Real?

This episode is 9 minutes long.

When was this This Podcast is Not Real episode published?

This episode was published on October 17, 2024.

Can I download this This Podcast is Not Real episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!